JPS5411319B2 - - Google Patents

Info

Publication number
JPS5411319B2
JPS5411319B2 JP11916874A JP11916874A JPS5411319B2 JP S5411319 B2 JPS5411319 B2 JP S5411319B2 JP 11916874 A JP11916874 A JP 11916874A JP 11916874 A JP11916874 A JP 11916874A JP S5411319 B2 JPS5411319 B2 JP S5411319B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11916874A
Other languages
Japanese (ja)
Other versions
JPS5088085A (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5088085A publication Critical patent/JPS5088085A/ja
Publication of JPS5411319B2 publication Critical patent/JPS5411319B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP11916874A 1973-11-09 1974-10-16 Expired JPS5411319B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS7700A CS171787B1 (cg-RX-API-DMAC7.html) 1973-11-09 1973-11-09

Publications (2)

Publication Number Publication Date
JPS5088085A JPS5088085A (cg-RX-API-DMAC7.html) 1975-07-15
JPS5411319B2 true JPS5411319B2 (cg-RX-API-DMAC7.html) 1979-05-14

Family

ID=5426587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11916874A Expired JPS5411319B2 (cg-RX-API-DMAC7.html) 1973-11-09 1974-10-16

Country Status (15)

Country Link
US (1) US3980631A (cg-RX-API-DMAC7.html)
JP (1) JPS5411319B2 (cg-RX-API-DMAC7.html)
AR (1) AR207765A1 (cg-RX-API-DMAC7.html)
BE (1) BE822062A (cg-RX-API-DMAC7.html)
CA (1) CA1020547A (cg-RX-API-DMAC7.html)
CH (1) CH610879A5 (cg-RX-API-DMAC7.html)
CS (1) CS171787B1 (cg-RX-API-DMAC7.html)
DE (1) DE2452279A1 (cg-RX-API-DMAC7.html)
DK (1) DK567474A (cg-RX-API-DMAC7.html)
FR (1) FR2250751B1 (cg-RX-API-DMAC7.html)
GB (1) GB1440859A (cg-RX-API-DMAC7.html)
IN (1) IN140167B (cg-RX-API-DMAC7.html)
IT (1) IT1056739B (cg-RX-API-DMAC7.html)
NL (1) NL7414490A (cg-RX-API-DMAC7.html)
SE (1) SE419753B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235881A (en) * 1978-12-04 1980-11-25 Cort Joseph H Method for producing high potency factor VIII
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4551445A (en) * 1983-10-14 1985-11-05 The Medical College Of Ohio Derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
IE58407B1 (en) * 1984-04-13 1993-09-22 Akzo Nv Peptides
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US4786631A (en) * 1988-03-18 1988-11-22 University Of Florida Novel arginine vasopressin-binding peptides
US6028168A (en) * 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
WO1995026719A1 (en) * 1994-04-01 1995-10-12 Arcturus Pharmaceutical Corporation Method for delivering biologically active materials using a thioester or thioether prodrug
US5562812A (en) * 1995-04-03 1996-10-08 The Penn State Research Foundation Free flow electrophoresis device for biomolecule purification and separation in zero and one G
SG10201509152VA (en) 2008-12-22 2015-12-30 Allergan Inc Intranasal desmopressin administration
US20100160214A1 (en) * 2008-12-22 2010-06-24 Serenity Pharmaceuticals Corporation Desmopressin composition
CA2765221C (en) 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration

Also Published As

Publication number Publication date
IN140167B (cg-RX-API-DMAC7.html) 1976-09-25
FR2250751A1 (cg-RX-API-DMAC7.html) 1975-06-06
AR207765A1 (es) 1976-10-29
IT1056739B (it) 1982-02-20
DK567474A (cg-RX-API-DMAC7.html) 1975-07-07
CS171787B1 (cg-RX-API-DMAC7.html) 1976-11-29
CA1020547A (en) 1977-11-08
SE7411817L (cg-RX-API-DMAC7.html) 1975-05-12
DE2452279A1 (de) 1975-05-15
FR2250751B1 (cg-RX-API-DMAC7.html) 1979-05-11
JPS5088085A (cg-RX-API-DMAC7.html) 1975-07-15
US3980631A (en) 1976-09-14
NL7414490A (nl) 1975-05-13
SE419753B (sv) 1981-08-24
BE822062A (fr) 1975-03-03
CH610879A5 (cg-RX-API-DMAC7.html) 1979-05-15
GB1440859A (en) 1976-06-30

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC7.html)
AR201235Q (cg-RX-API-DMAC7.html)
AR201231Q (cg-RX-API-DMAC7.html)
AU474593B2 (cg-RX-API-DMAC7.html)
AU465453B2 (cg-RX-API-DMAC7.html)
AU471343B2 (cg-RX-API-DMAC7.html)
FR2250751B1 (cg-RX-API-DMAC7.html)
AU450229B2 (cg-RX-API-DMAC7.html)
AU476714B2 (cg-RX-API-DMAC7.html)
AR201229Q (cg-RX-API-DMAC7.html)
AR199451A1 (cg-RX-API-DMAC7.html)
AU472848B2 (cg-RX-API-DMAC7.html)
AU476696B2 (cg-RX-API-DMAC7.html)
AU466283B2 (cg-RX-API-DMAC7.html)
AU476873B1 (cg-RX-API-DMAC7.html)
AU461342B2 (cg-RX-API-DMAC7.html)
AR195311A1 (cg-RX-API-DMAC7.html)
AR210729A1 (cg-RX-API-DMAC7.html)
AU477824B2 (cg-RX-API-DMAC7.html)
AR193950A1 (cg-RX-API-DMAC7.html)
AR196382A1 (cg-RX-API-DMAC7.html)
AR195948A1 (cg-RX-API-DMAC7.html)
AR200885A1 (cg-RX-API-DMAC7.html)
AR200256A1 (cg-RX-API-DMAC7.html)
AR197627A1 (cg-RX-API-DMAC7.html)